We are live on
!
Find out more
HTC
Hershey Trust Company Portfolio holdings
AUM
$11.8B
1-Year Est. Return
0.75%
This Fund
S&P 500
This Quarter
Est. Return
+0.04%
1 Year Est. Return
+0.75%
3 Year Est. Return
-0.55%
5 Year Est. Return
-0.68%
10 Year Est. Return
+3.33%
AUM
$10.7B
AUM Growth
+$994M
(+10%)
Cap. Flow
+$19.1M
Cap. Flow
% of AUM
0.18%
Top 10 Holdings %
Top 10 Hldgs %
99.87%
Holding
42
New
7
Increased
7
Reduced
3
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE Small-Cap ETF
SCZ
|
+$13.6M |
| 2 |
Pinduoduo
PDD
|
+$2.85M |
| 3 |
Teladoc Health
TDOC
|
+$1.77M |
| 4 |
CRISPR Therapeutics
CRSP
|
+$930K |
| 5 |
Nurix Therapeutics
NRIX
|
+$259K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$2.7M |
| 2 |
Wayfair
W
|
+$1.32M |
| 3 |
CMRC
Commerce.com Inc Series 1
CMRC
|
+$1.32M |
| 4 |
Lemonade
LMND
|
+$894K |
| 5 |
RPTX
Repare Therapeutics
RPTX
|
+$158K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 0.11% |
| 2 | Consumer Staples | 0.08% |
| 3 | Consumer Discretionary | 0.03% |
| 4 | Technology | 0.01% |
| 5 | Communication Services | 0.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OYST
26
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $152K | ﹤0.01% |
8,861
| – | – |
|
|
JNCE
27
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $149K | ﹤0.01% |
21,948
+12,058
| +122% | +$100K |
|
28
Aligos Therapeutics
ALGS
$26.3M
| $124K | ﹤0.01% |
+243
| New | +$155K |
|
|
EGRX
29
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $92K | ﹤0.01% |
2,138
| – | – |
|
30
Aprea Therapeutics
APRE
$7.69M
| $48K | ﹤0.01% |
491
| – | – |
|
|
ADVM
31
DELISTED
Adverum Biotechnologies
ADVM
| $13K | ﹤0.01% |
371
| – | – |
|
|
NOAH
32
Noah Holdings
NOAH
$590M
| $12K | ﹤0.01% |
253
| – | – |
|
|
CMRC
33
Commerce.com Inc Series 1
CMRC
$272M
| – | – |
-22,766
| Closed | -$1.32M |
|
34
Glaukos
GKOS
$9.49B
| – | – |
-983
| Closed | -$83K |
|
|
35
Lemonade
LMND
$3.64B
| – | – |
-9,596
| Closed | -$894K |
|
|
36
Wayfair
W
$11.8B
| – | – |
-4,203
| Closed | -$1.32M |
|
|
MRO
37
DELISTED
Marathon Oil Corporation
MRO
| – | – |
-134
| Closed | -$1K |
|
Similar funds
VA
BCI
VIA
NYLIM
PI
UE
LC
MG
Hershey Trust Company's Q2 2021 Portfolio in Review
As of Q2 2021, Hershey Trust Company held 42 positions worth $10.7B, up 10% from $9.67B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Hershey Trust Company's Q2 2021 filing shows 7 new, 7 increased, 3 reduced and 5 closed positions. Its largest new stake was Pinduoduo: 21,923 shares worth $2.79M. The largest sale was iShares Russell 2000 ETF, an estimated $2.7M.
By sector, the portfolio is most concentrated in Healthcare at 0.11% of assets, up from 0.09% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.
- Hershey Trust Company's largest Q2 2021 buy was Pinduoduo: 21,923 shares worth $2.79M.
- Hershey Trust Company added most to iShares MSCI EAFE Small-Cap ETF in Q2 2021, an estimated $13.6M increase.
- Hershey Trust Company's biggest Q2 2021 reduction was iShares Russell 2000 ETF, cutting an estimated $2.7M.
- Hershey Trust Company fully exited Wayfair in Q2 2021, selling an estimated $1.32M.
- Hershey Trust Company's ten largest holdings make up 100% of its $10.7B portfolio in Q2 2021.
- Hershey Trust Company opened 7 new positions and closed 5 in Q2 2021.
- Hershey Trust Company's portfolio value rose 10% quarter-over-quarter to $10.7B.
Based on Hershey Trust Company's 13F filing for Q2 2021, filed 11 Aug 2021.